DK1716119T3 - Analoger af benzoquinonholdige ansamyciner til behandling af cancer - Google Patents

Analoger af benzoquinonholdige ansamyciner til behandling af cancer

Info

Publication number: DK1716119T3
Authority: DK; Denmark
Prior art keywords: anamicycines; benzoquinon; analogs; cancer; treatment
Prior art date: 2003-12-23

Application number

DK04817048.4T

Other languages

English (en)

Inventor

Julian Adams

Yun Gao

Evangelinos Asimina T Georges

Louis Grenier

Roger H Pak

James R Porter

James L Wright

Original Assignee

Infinity Discovery Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-23

Publication date

2013-06-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34744040&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1716119(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-23 Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc

2013-06-10 Application granted granted Critical

2013-06-10 Publication of DK1716119T3 publication Critical patent/DK1716119T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Oncology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK04817048.4T 2003-12-23 2004-12-23 Analoger af benzoquinonholdige ansamyciner til behandling af cancer DK1716119T3 (da)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US53208003P	2003-12-23	2003-12-23
US54014204P	2004-01-29	2004-01-29
US54738104P	2004-02-23	2004-02-23
US56171804P	2004-04-12	2004-04-12
US56756504P	2004-05-03	2004-05-03
US60628304P	2004-09-01	2004-09-01
US62628604P	2004-11-09	2004-11-09
US63285804P	2004-12-03	2004-12-03
PCT/US2004/043162 WO2005063714A1 (en)	2003-12-23	2004-12-23	Analogs of benzoquinone-containing ansamycins for the treatment of cancer

Publications (1)

Publication Number	Publication Date
DK1716119T3 true DK1716119T3 (da)	2013-06-10

Family

ID=34744040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04817048.4T DK1716119T3 (da)	2003-12-23	2004-12-23	Analoger af benzoquinonholdige ansamyciner til behandling af cancer

Country Status (15)

Country	Link
US (13)	US7282493B2 (da)
EP (2)	EP1716119B1 (da)
JP (2)	JP4869077B2 (da)
KR (1)	KR101154351B1 (da)
CN (1)	CN102643233B (da)
AU (1)	AU2004309395C1 (da)
BR (1)	BRPI0418147A (da)
CA (1)	CA2547343C (da)
DK (1)	DK1716119T3 (da)
ES (1)	ES2409351T3 (da)
IL (2)	IL175911A (da)
NO (1)	NO337933B1 (da)
PT (1)	PT1716119E (da)
RU (1)	RU2484086C9 (da)
WO (1)	WO2005063714A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090197852A9 (en) *	2001-08-06	2009-08-06	Johnson Robert G Jr	Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
US7282493B2 (en)	2003-12-23	2007-10-16	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20060019941A1 (en) *	2003-12-23	2006-01-26	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
MX2007004893A (es) *	2004-11-02	2007-06-14	Conforma Therapeutics Corp	Metodos y composiciones para el tratamiento de leucemia linfocitica cronica.
US10252088B2 (en)	2004-12-02	2019-04-09	Obagi Cosmeceuticals Llc	Topical compositions and methods of manufacturing them in specifically treated steel vessels
WO2006098761A2 (en)	2005-03-11	2006-09-21	The Regents Of The University Of Colorado	Hsp90 inhibitors, methods of making and uses therefor
US11457813B2 (en)	2005-03-29	2022-10-04	Martin W. Roche	Method for detecting body parameters
CN101175489A (zh) *	2005-04-29	2008-05-07	高山生物科学股份有限公司	用17-aag或17-ag或其前药治疗多发性骨髓瘤的方法
GB0517886D0 (en) *	2005-09-02	2005-10-12	Biotica Tech Ltd	Novel compounds
US20090042847A1 (en) *	2005-11-23	2009-02-12	Kosan Biosciences Incorporated	17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
US20070207992A1 (en) *	2006-02-21	2007-09-06	Board Of Trustees Of Michigan State University	Geldanamycin derivatives and method of use thereof
GB0606548D0 (en) *	2006-03-31	2006-05-10	Biotica Tech Ltd	Novel compounds and methods for their production
JP5528806B2 (ja)	2006-10-12	2014-06-25	アステックス、セラピューティックス、リミテッド	複合薬剤
EP2073807A1 (en)	2006-10-12	2009-07-01	Astex Therapeutics Limited	Pharmaceutical combinations
FR2907453B1 (fr)	2006-10-24	2008-12-26	Sanofi Aventis Sa	Nouveaux derives du fluorene,compositions les contenant et utilisation
MX2009004775A (es) *	2006-11-09	2009-05-21	Biotica Tech Ltd	Nuevos compuestos y metodos para su produccion.
PE20081506A1 (es) *	2006-12-12	2008-12-09	Infinity Discovery Inc	Formulaciones de ansamicina
JP2010516282A (ja) *	2007-01-26	2010-05-20	コーサンバイオサイエンシーズ，インコーポレイテッド	工学的生合成によるマクロラクタム
BRPI0810835A2 (pt) *	2007-04-12	2015-06-16	Infinity Discovery Inc	Formulações de hidroquinona ansamicina
EP2068904B1 (en) *	2007-06-07	2012-12-05	Joyant Pharmaceuticals, Inc.	Methods for preparing diazonamides
US8551964B2 (en)	2007-08-23	2013-10-08	The Regents Of The University Of Colorado	Hsp90 inhibitors with modified toxicity
CN102245021B (zh) *	2008-10-15	2014-09-17	无限药品公司	安莎霉素氢醌组合物
US8669289B2 (en) *	2009-04-24	2014-03-11	The Jackson Laboratory	Methods and compositions relating to hematologic malignancies
WO2010135426A1 (en) *	2009-05-19	2010-11-25	Infinity Pharmaceuticals, Inc.	Methods of treating liposarcoma
AR077405A1 (es)	2009-07-10	2011-08-24	Sanofi Aventis	Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr)	2009-09-03	2011-11-25	Sanofi Aventis	Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
EP2499486A4 (en) *	2009-11-13	2013-11-27	Infinity Pharmaceuticals Inc	COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, EVALUATION, PREVENTION, AND THERAPY OF CANCER
US9603829B2 (en)	2011-11-14	2017-03-28	The Regents Of The University Of Colorado, A Body Corporate	HSP90 inhibitors with modified toxicity
KR102833837B1 (ko) *	2015-09-19	2025-07-11	어플라이드 머티어리얼스, 인코포레이티드	하이드로실릴화 패시베이션을 사용한 표면 선택적 원자 층 증착
US10052304B2 (en) *	2015-10-12	2018-08-21	University Of Iowa Research Foundation	Compositions and methods for cancer therapy
HUE046449T2 (hu)	2016-09-13	2020-03-30	Allergan Inc	Stabilizált, nem fehérje eredetû, clostridiális toxin készítmények

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US123640A (en)		1872-02-13		Improvement in tab-plates of buckles
US120578A (en)		1871-11-07		Improvement in letter-boxes
US745718A (en) *	1903-04-25	1903-12-01	Owen Thomas Dougherty	Weight-indicating sliding and spring support for vehicle-bodies.
GB210611A (en) *	1923-01-16	1924-02-07	Clarence Hancock	Improved means of heating garden propagating frames, foster mothers and the like
US3595955A (en)	1969-03-26	1971-07-27	Upjohn Co	Geldanamycin and process for producing same
JPS5470299A (en) *	1977-11-14	1979-06-05	Takeda Chem Ind Ltd	Production of maytansine derivative
US4261989A (en)	1979-02-19	1981-04-14	Kaken Chemical Co. Ltd.	Geldanamycin derivatives and antitumor drug
JPS5874651A (ja) *	1981-09-17	1983-05-06	Takeda Chem Ind Ltd	マクベシン誘導体およびその製造法
DE3234203A1 (de) *	1981-09-17	1983-07-07	Takeda Chemical Industries, Ltd., Osaka	Macbecin-derivate und deren herstellung
US4762857A (en) *	1986-05-30	1988-08-09	E. I. Du Pont De Nemours And Company	Trehalose as stabilizer and tableting excipient
ZA878877B (en)	1986-11-29	1988-05-24	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Treatment of diseases caused by viruses
CA2127457A1 (en)	1992-01-06	1993-07-22	Walter P. Cullen	Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone
US5397584A (en) *	1992-12-09	1995-03-14	Mccormick & Company, Inc.	Process for preparing stabilized, partially-dehydrated aromatic plant products
US5387584A (en)	1993-04-07	1995-02-07	Pfizer Inc.	Bicyclic ansamycins
WO1995001342A1 (en) *	1993-06-29	1995-01-12	Pfizer Inc.	Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en)	1994-06-16	1999-08-03	Pfizer Inc.	Ansamycin derivatives as antioncogene and anticancer agents
AU707734B2 (en)	1995-06-07	1999-07-15	Regents Of The University Of California, The	Stabilization of polynucleotide complexes
US5968921A (en)	1997-10-24	1999-10-19	Orgegon Health Sciences University	Compositions and methods for promoting nerve regeneration
ZA9811127B (en)	1997-12-09	2000-07-11	Lilly Co Eli	Stabilized teriparatide solutions.
AU3378599A (en)	1998-04-03	1999-10-25	University Of Pittsburgh	Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke
WO2000003737A2 (en)	1998-07-17	2000-01-27	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Water-soluble drugs and methods for their production
US6174875B1 (en)	1999-04-01	2001-01-16	University Of Pittsburgh	Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke
WO2002002123A1 (en)	2000-06-29	2002-01-10	Trustees Of Boston University	Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders
EP1322307B1 (en)	2000-07-28	2011-09-28	Sloan-Kettering Institute For Cancer Research	Methods for treating cell proliferative disorders and viral infections
ATE334119T1 (de)	2001-03-30	2006-08-15	Us Health	Geldanamycinderivate zur krebsbehandlung
JP2005515164A (ja) *	2001-08-06	2005-05-26	コーサンバイオサイエンシーズ，インコーポレイテッド	ベンゾキノンアンサマイシン
US6872715B2 (en)	2001-08-06	2005-03-29	Kosan Biosciences, Inc.	Benzoquinone ansamycins
AU2002330998A1 (en) *	2001-08-06	2003-02-24	Kosan Biosciences, Inc.	Benzoquinone ansamycins
CN100378079C (zh)	2001-09-24	2008-04-02	康福玛医药公司	用于制备17-烯丙基氨基格尔德霉素(17-aag)以及其它袢霉素的方法
CA2468202A1 (en) *	2001-12-12	2003-06-19	Conforma Therapeutics Corporation	Assays and implements for determining and modulating hsp90 binding activity
ATE433961T1 (de)	2002-02-08	2009-07-15	Conforma Therapeutics Corp	Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
TW200303363A (en)	2002-02-25	2003-09-01	Upjohn Co	Process to prepare and isolate geldanamycin
PL207018B1 (pl)	2002-06-21	2010-10-29	Novo Nordisk Helth Care Ag	Kompozycja farmaceutyczna, sposób przygotowania stabilnego polipeptydu czynnika VII i zastosowanie polipeptydu czynnika VII
JP2006514994A (ja)	2003-03-13	2006-05-18	コンフォーマ・セラピューティクス・コーポレイション	長鎖および中鎖トリグリセリドを有する医薬製剤
US20060019941A1 (en)	2003-12-23	2006-01-26	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
US7282493B2 (en)	2003-12-23	2007-10-16	Infinity Pharmaceuticals, Inc.	Analogs of benzoquinone-containing ansamycins and methods of use thereof
EP1737825A1 (en)	2004-03-26	2007-01-03	Van Andel Research Institute	Geldanamycin and derivatives inhibit cancer invasion and identify novel targets
WO2006098761A2 (en)	2005-03-11	2006-09-21	The Regents Of The University Of Colorado	Hsp90 inhibitors, methods of making and uses therefor
US20100279994A1 (en)	2005-06-21	2010-11-04	Inifinity Discovery, Inc.	Ansamycin Formulations and Methods of Use Thereof
CN101213178A (zh)	2005-06-29	2008-07-02	协和发酵工业株式会社	苯环型安莎霉素衍生物
AU2006320435A1 (en)	2005-12-01	2007-06-07	Conforma Therapeutics Corporation	Compositions containing ansamycin
PE20081506A1 (es)	2006-12-12	2008-12-09	Infinity Discovery Inc	Formulaciones de ansamicina
BRPI0810835A2 (pt)	2007-04-12	2015-06-16	Infinity Discovery Inc	Formulações de hidroquinona ansamicina
US9907242B2 (en)	2016-02-18	2018-03-06	Seminis Vegetable Seeds, Inc.	Pepper hybrid SV5873HE

2004
- 2004-12-23 US US11/022,057 patent/US7282493B2/en not_active Expired - Fee Related
- 2004-12-23 RU RU2006126797/04A patent/RU2484086C9/ru not_active IP Right Cessation
- 2004-12-23 WO PCT/US2004/043162 patent/WO2005063714A1/en not_active Ceased
- 2004-12-23 CA CA2547343A patent/CA2547343C/en not_active Expired - Fee Related
- 2004-12-23 AU AU2004309395A patent/AU2004309395C1/en not_active Ceased
- 2004-12-23 ES ES04817048T patent/ES2409351T3/es not_active Expired - Lifetime
- 2004-12-23 EP EP04817048A patent/EP1716119B1/en not_active Expired - Lifetime
- 2004-12-23 JP JP2006547323A patent/JP4869077B2/ja not_active Expired - Fee Related
- 2004-12-23 KR KR1020067014822A patent/KR101154351B1/ko not_active Expired - Fee Related
- 2004-12-23 CN CN201210093005.4A patent/CN102643233B/zh not_active Expired - Fee Related
- 2004-12-23 BR BRPI0418147-6A patent/BRPI0418147A/pt active Search and Examination
- 2004-12-23 EP EP12168729.7A patent/EP2492261B1/en not_active Expired - Lifetime
- 2004-12-23 DK DK04817048.4T patent/DK1716119T3/da active
- 2004-12-23 PT PT48170484T patent/PT1716119E/pt unknown
2005
- 2005-04-13 US US11/105,203 patent/US7566706B2/en not_active Expired - Fee Related
- 2005-04-14 US US11/108,165 patent/US7375217B2/en not_active Expired - Fee Related
- 2005-04-14 US US11/107,404 patent/US7361647B2/en not_active Expired - Fee Related
2006
- 2006-05-25 IL IL175911A patent/IL175911A/en not_active IP Right Cessation
- 2006-06-12 NO NO20062707A patent/NO337933B1/no not_active IP Right Cessation
2008
- 2008-08-27 US US12/199,211 patent/US7608613B2/en not_active Expired - Fee Related
- 2008-08-27 US US12/199,356 patent/US7767662B2/en not_active Expired - Fee Related
- 2008-08-27 US US12/199,415 patent/US7579337B2/en not_active Expired - Fee Related
- 2008-08-27 US US12/199,578 patent/US7833997B2/en not_active Expired - Fee Related
2009
- 2009-02-11 US US12/369,545 patent/US7767663B2/en not_active Expired - Fee Related
- 2009-02-11 US US12/369,549 patent/US7691840B2/en not_active Expired - Fee Related
2010
- 2010-07-14 IL IL206984A patent/IL206984A/en not_active IP Right Cessation
- 2010-10-06 US US12/899,187 patent/US8003634B2/en not_active Expired - Fee Related
2011
- 2011-07-27 US US13/191,761 patent/US8252779B2/en not_active Expired - Fee Related
- 2011-08-04 JP JP2011170747A patent/JP5313308B2/ja not_active Expired - Fee Related
2012
- 2012-08-20 US US13/589,581 patent/US8703755B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20090253653A1 (en)	2009-10-08
US20090088414A1 (en)	2009-04-02
US20050288269A1 (en)	2005-12-29
CA2547343A1 (en)	2005-07-14
JP2007528875A (ja)	2007-10-18
US20090208590A1 (en)	2009-08-20
EP1716119A1 (en)	2006-11-02
RU2006126797A (ru)	2008-01-27
US7579337B2 (en)	2009-08-25
US20120058982A1 (en)	2012-03-08
KR101154351B1 (ko)	2012-06-15
PT1716119E (pt)	2013-06-04
US20090209549A1 (en)	2009-08-20
US20060014731A1 (en)	2006-01-19
AU2004309395A1 (en)	2005-07-14
IL175911A (en)	2012-01-31
NO337933B1 (no)	2016-07-11
US7691840B2 (en)	2010-04-06
NO20062707L (no)	2006-09-11
JP5313308B2 (ja)	2013-10-09
AU2004309395C1 (en)	2012-10-04
BRPI0418147A (pt)	2007-04-17
US7375217B2 (en)	2008-05-20
US8703755B2 (en)	2014-04-22
EP2492261B1 (en)	2015-02-18
US7361647B2 (en)	2008-04-22
US20110086110A1 (en)	2011-04-14
KR20060132660A (ko)	2006-12-21
IL206984A (en)	2015-02-26
HK1097410A1 (en)	2007-06-22
US20090069280A1 (en)	2009-03-12
AU2004309395B2 (en)	2011-10-06
WO2005063714A1 (en)	2005-07-14
CA2547343C (en)	2013-05-14
US20060019939A1 (en)	2006-01-26
CN102643233A (zh)	2012-08-22
US20090062250A1 (en)	2009-03-05
US7608613B2 (en)	2009-10-27
IL175911A0 (en)	2006-10-05
JP4869077B2 (ja)	2012-02-01
US7767663B2 (en)	2010-08-03
US20130203724A1 (en)	2013-08-08
US8252779B2 (en)	2012-08-28
EP1716119B1 (en)	2013-03-06
IL206984A0 (en)	2011-07-31
US8003634B2 (en)	2011-08-23
US20050227955A1 (en)	2005-10-13
RU2484086C2 (ru)	2013-06-10
CN102643233B (zh)	2015-11-25
ES2409351T3 (es)	2013-06-26
US7767662B2 (en)	2010-08-03
US7566706B2 (en)	2009-07-28
US7833997B2 (en)	2010-11-16
EP2492261A1 (en)	2012-08-29
JP2011225614A (ja)	2011-11-10
US7282493B2 (en)	2007-10-16
RU2484086C9 (ru)	2013-08-20

Publication	Publication Date	Title
DK1716119T3 (da)	2013-06-10	Analoger af benzoquinonholdige ansamyciner til behandling af cancer
DK1701941T3 (da)	2012-08-13	Forbindelser til behandling af sygdomme med celleproliferation
DK1781604T3 (da)	2013-09-16	Bis(thio-hydrazid-amid)-salte til behandling af cancere
DK1765391T3 (da)	2013-03-25	Bakterielle præparater til behandlingen af cancer
DK1944322T3 (da)	2015-06-22	Behandling af TNFalfa-relaterede sygdomme
DK1720571T3 (da)	2012-09-03	Fremgangsmåde til behandling af hæmolytisk sygdom
CY2015003I2 (el)	2015-12-09	Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
IS2935B (is)	2016-01-15	Misnotkunarvarið lyfjaform til skömmtunar um húð
DK2308507T3 (da)	2015-04-20	Fremgangsmåder til behandling af præeklampsi
DK3470535T3 (da)	2020-06-29	Forudsigelse af sandsynlighed for tilbagevenden af cancer
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1608634T3 (da)	2013-08-12	Fremgangsmåder til isolering af krystallinsk form af 5-azacytidin
DK1716162T3 (da)	2011-01-10	Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
DK1755671T3 (da)	2013-03-25	Terapi af platinresistent cancer
DK1663287T3 (da)	2009-11-09	Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme
DK1446012T3 (da)	2013-10-14	Bakteriolytisk kombinationsterapi til behandling af tumorer
DK1708992T3 (da)	2007-11-05	Sulfonamidderivater til behandling af sygdomme
DK1499730T3 (da)	2014-01-13	Immunokonjugater til behandling af tumorer
IS8125A (is)	2005-11-11	Kínasólínafleiður til að meðhöndla krabbamein
DK1708991T3 (da)	2008-01-14	Sulfonamid derivater til behandling af sygdomme
FI20060154L (fi)	2006-02-17	Neurogeneratiivisten tilojen hoito
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1694122T3 (da)	2007-12-03	N-arylhydrazonderivater til fröbehandling
DK1516540T3 (da)	2012-11-26	Anvendelse af vitamin D-forbindelser
DK1727801T3 (da)	2009-05-11	Til behandling af smerter anvendelige piperaziner